Prilovix Ultralite Plus Interactions
There are 51 drugs known to interact with Prilovix Ultralite Plus (lidocaine / prilocaine topical), along with 7 disease interactions. Of the total drug interactions, 43 are major, and 8 are moderate.
- View all 51 medications that may interact with Prilovix Ultralite Plus
- View Prilovix Ultralite Plus disease interactions (7)
Most frequently checked interactions
View interaction reports for Prilovix Ultralite Plus (lidocaine / prilocaine topical) and the medicines listed below.
- acetaminophen
- acetaminophen
- Adcetris (brentuximab)
- Adcetris (brentuximab)
- amlodipine
- amlodipine
- atorvastatin
- atorvastatin
- Benadryl (diphenhydramine)
- Benadryl (diphenhydramine)
- betamethasone
- betamethasone
- bexarotene
- bexarotene
- cetirizine
- cetirizine
- ciprofloxacin
- ciprofloxacin
- clotrimazole topical
- clotrimazole topical
- Coricidin HBP Maximum Strength Flu (acetaminophen / chlorpheniramine / dextromethorphan)
- Coricidin HBP Maximum Strength Flu (acetaminophen / chlorpheniramine / dextromethorphan)
- diclofenac
- diclofenac
- diphenhydramine / hydrocodone / phenylephrine
- diphenhydramine / hydrocodone / phenylephrine
- doxycycline
- doxycycline
- Duobrii (halobetasol / tazarotene topical)
- Duobrii (halobetasol / tazarotene topical)
Prilovix Ultralite Plus disease interactions
There are 7 disease interactions with Prilovix Ultralite Plus (lidocaine / prilocaine topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- methemoglobinemia
- renal/hepatic dysfunction
Report options
QR code containing a link to this page
More about Prilovix Ultralite Plus (lidocaine / prilocaine topical)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.